Therapeutic Development Paths for Cognitive Impairment in Parkinson's Disease: Report of a Regulatory Roundtable
Authors:
Open Access
- 1 January 2014
- journal article
- review article
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 4 (4) , 585-589
Abstract
Cognitive impairment is a common occurrence in Parkinson's disease (PD), although the severity and specific presentation varies across patients. Initial deficits, including mild cognitive impairment (PD-MCI), may remain stable or in many cases, may pKeywords
This publication has 26 references indexed in Scilit:
- What can biomarkers tell us about cognition in Parkinson's disease?Movement Disorders, 2014
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's DiseaseNew England Journal of Medicine, 2009
- Parkinson's disease‐cognitive rating scale: A new cognitive scale specific for Parkinson's diseaseMovement Disorders, 2008
- Clinical diagnostic criteria for dementia associated with Parkinson's diseaseMovement Disorders, 2007
- COGNITIVE REHABILITATION IN PARKINSON’S DISEASEArchives of Gerontology and Geriatrics, 2004
- Assessment of cognition in Parkinson’s diseaseNeurology, 2003
- The Disability Assessment for Dementia Scale: A 12-Month Study of Functional Ability in Mild to Moderate Severity Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 2001
- Mild Cognitive ImpairmentArchives of Neurology, 1999
- A new rating scale for Alzheimer's diseaseAmerican Journal of Psychiatry, 1984
- “Mini-mental state”Journal of Psychiatric Research, 1975